| Kevin Wayne Schell, | |
|
1201 S Miller St, Wenatchee, WA 98801-3201 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Kevin Wayne Schell |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 1201 S Miller St, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043385719 | NPI | - | NPPES |
| 0663623 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL60235014 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Wayne Schell, 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Kevin Wayne Schell, 1201 S Miller St, Wenatchee, WA 98801-3201 Ph: (509) 663-8711 |
News Archive
A study of patients and members of the public has shown that most lack even basic knowledge of human anatomy. The research, featured in the open access journal BMC Family Practice, found that people were generally incapable of identifying the location of major organs, even if they were currently receiving relevant treatment.
However, in other research, white blood cells' exact roles and subtypes in severe COVID-19 are still unclear. The team writes, "It is unknown if blood cell counts before infection are associated with the risk of developing severe COVID-19." They explained that the numbers of these cell types could be influenced by several factors such as age, gender, disease status, and medications.
Nearly 2,500 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 56th American Society of Tropical Medicine and Hygiene's Annual Meeting on Nov. 4-8, in Philadelphia to discuss the latest research on infectious diseases and bioterrorist and global health threats.
Nymox Pharmaceutical Corporation today announced new 2010 positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's NX02-0012 and NX02-0013 Phase 1-2 studies of NX-1207 initially undertaken in 2003. Patients treated with NX-1207 were followed-up on an unselected and as available basis and assessed for symptomatic improvement, treatment outcomes, and durability of efficacy 6 ½ years after a single treatment with NX-1207.
By engineering antibacterial enzymes, Dartmouth investigators led by Karl Griswold, PhD are using novel strategies to target the prevalent drug-resistant bacterium Staphylococcus aureus.
› Verified 8 days ago
Alexis Mary Elwood, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 S Mission St, Wenatchee, WA 98801 Phone: 509-888-2505 | |
Erica Batjer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Tonya Lee Asmussen, MA CF SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Mrs. Elizabeth Anne Mclaughlin, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 112 Elliott Ave S, Wenatchee, WA 98801 Phone: 509-663-7117 | |
Mrs. Jean Coughlin Richtsmeier, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 N Mission St, Ste B, Wenatchee, WA 98801 Phone: 509-888-2505 Fax: 509-888-2507 | |
Philip Gregg, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 224 Methow St, Wenatchee, WA 98801 Phone: 509-663-5710 |